Angiodynamics (ANGO) EPS (Basic) Growth (5y) (2015 - 2026)
Powered by 
Analysis
Angiodynamics (ANGO) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.91 Bn | 175.30 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.79 Bn | 122.57 Bn | 1.96 Bn |
| 3 | Medtronic | 116.85 Bn | 108.03 Bn | 6.34 Bn |
| 4 | Stryker | 104.37 Bn | 100.89 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.81 Bn | 63.27 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn |
| 8 | Dexcom | 32.19 Bn | 30.25 Bn | 830.00 Mn |
| 9 | Steris | 20.67 Bn | 20.18 Bn | 684.20 Mn |
| 10 | Angiodynamics | 626.63 Mn | 572.76 Mn | 46.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 11.56% |
| Feb 28, 2026 | -16.04% |
| Nov 30, 2025 | -6.54% |
| Aug 31, 2025 | -18.81% |
| May 31, 2025 | 48.62% |
| Feb 28, 2025 | 6.41% |
| Nov 30, 2024 | -29.51% |
| Aug 31, 2024 | -56.30% |
| May 31, 2024 | -17.22% |
| Feb 29, 2024 | -194.61% |
| Nov 30, 2023 | -71.08% |
| Aug 31, 2023 | 147.91% |
| May 31, 2023 | -11.59% |
| Feb 28, 2023 | -20.03% |
| Nov 30, 2022 | -29.36% |
| Aug 31, 2022 | -34.94% |
| May 31, 2022 | 25.11% |
| Feb 28, 2022 | -29.26% |
| Nov 30, 2021 | -20.81% |
| Aug 31, 2021 | -47.70% |